Global Cell & Gene Therapy Manufacturing Services Market Size study, by Type(Cell Therapy, Gene Therapy ), by Indication (Oncology Diseases, Cardiovascular Diseases, Orthopedic Diseases, Other Indications), by Application( Clinical Manufacturing, Commercial Manufacturing), by End user( Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Other End Users)and Regional Forecasts 2021-2027
- Category: Healthcare
- Published Date: Sep 2021
- Publisher: Bizwit Research
- Pages: 200
Global Cell & Gene Therapy Manufacturing Services Market is valued at approximately USD 6.9 million in 2020 and is anticipated to grow with a healthy growth rate of more than 12.4 % over the forecast period 2021-2027. The rising incidence of cancer and other target diseases, increasing spending in pharmaceutical R&D, investments in sophisticated technologies by CDMOs, and increasing partnerships and agreements between pharmaceutical firms and CDMOs are all driving growth in this industry. The high operational expenses associated with cell and gene therapy manufacturing, on the other hand, are projected to limit the market's expansion to some extent. Most of pharmaceutical companies continue to make significant investments in the development of new medications and equipment. The pharmaceutical business is highly investing in in research and development to bring high-quality, innovative goods to market. The trend implies that major pharma companies are enhancing their R&D efficiencies by investing more in R&D in order to obtain long-term returns on their investment, as well as through collaborating on R&D. According to a survey published by EvaluatePharma, global pharmaceutical R&D spending was valued at USD 136 billion in 2012, which reached to USD 186 billion in 2019. The worldwide pharma R&D growth rate has slowed to 0.3 percent between 2019 and 2020 as a result of COVID-19. According to the conclusions of the analysis, R&D spending is predicted to expand at a CAGR of 3.2 percent between 2019 and 2026, reaching USD 232.5 billion, slower than the historical CAGR of 4.6 percent between 2012 and 2019. The number of cell and gene therapy candidates in development has risen dramatically as a result of increased pharmaceutical R&D. To produce cost-effective and efficient cell and gene therapies, it has become vital to outsource manufacturing services. However, high operational costs associated with cell & gene therapy manufacturing may impede market growth over the forecast period of 2021-2027.
The regional analysis of the global Cell & Gene Therapy Manufacturing Services Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to rising incidence of cancer and growing research activity in cancer and stem cells in the region. Whereas Europe is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, A strong facility network coupled with a strong workforce in European countries is anticipated to further fuel the market growth.
Major market player included in this report are:
Thermo Fisher Scientific, Inc.
Merck KGaA
Charles River Laboratories
Lonza
Catalent, Inc.
Takara Bio Inc.
FUJIFILM Holdings Corporation
F. Hoffmann-La Roche Ltd.
The Discovery Labs LLC
Cell and Gene Therapy Catapult
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Cell Therapy
Gene Therapy
By Indication:
Oncology Diseases
Cardiovascular Diseases
Orthopedic Diseases
Other Indications
By Application:
Clinical Manufacturing
Commercial Manufacturing
By End user:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018-19
Base year – 2019-2020
Forecast period – 2021 to 2027.
Target Audience of the Global Cell & Gene Therapy Manufacturing Services Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of the global Cell & Gene Therapy Manufacturing Services Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to rising incidence of cancer and growing research activity in cancer and stem cells in the region. Whereas Europe is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, A strong facility network coupled with a strong workforce in European countries is anticipated to further fuel the market growth.
Major market player included in this report are:
Thermo Fisher Scientific, Inc.
Merck KGaA
Charles River Laboratories
Lonza
Catalent, Inc.
Takara Bio Inc.
FUJIFILM Holdings Corporation
F. Hoffmann-La Roche Ltd.
The Discovery Labs LLC
Cell and Gene Therapy Catapult
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Cell Therapy
Gene Therapy
By Indication:
Oncology Diseases
Cardiovascular Diseases
Orthopedic Diseases
Other Indications
By Application:
Clinical Manufacturing
Commercial Manufacturing
By End user:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018-19
Base year – 2019-2020
Forecast period – 2021 to 2027.
Target Audience of the Global Cell & Gene Therapy Manufacturing Services Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Cell & Gene Therapy Manufacturing Services Market , by Region, 2019-2027 (USD Billion)
1.2.2. Cell & Gene Therapy Manufacturing Services Market , by Type, 2019-2027 (USD Billion)
1.2.3. Cell & Gene Therapy Manufacturing Services Market , by Indication, 2019-2027 (USD Billion)
1.2.4. Cell & Gene Therapy Manufacturing Services Market , by Application, 2019-2027 (USD Billion)
1.2.5. Cell & Gene Therapy Manufacturing Services Market , by End user, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell & Gene Therapy Manufacturing Services Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell & Gene Therapy Manufacturing Services Market Dynamics
3.1. Cell & Gene Therapy Manufacturing Services Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. High incidence of cancer and other target diseases
3.1.1.2. Increasing investments in pharmaceutical R&D
3.1.2. Market Restraint
3.1.2.1. High operational costs associated with cell & gene therapy manufacturing
3.1.3. Market Opportunities
3.1.3.1. Rising demand for cell & gene therapies
Chapter 4. Global Cell & Gene Therapy Manufacturing Services Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cell & Gene Therapy Manufacturing Services Market , by Type
5.1. Market Snapshot
5.2. Global Cell & Gene Therapy Manufacturing Services Market by Type , Performance - Potential Analysis
5.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
5.4.1. Cell Therapy
5.4.2. Gene Therapy
Chapter 6. Global Cell & Gene Therapy Manufacturing Services Market , by Indication
6.1. Market Snapshot
6.2. Global Cell & Gene Therapy Manufacturing Services Market by Indication, Performance - Potential Analysis
6.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
6.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
6.4.1. Oncology Diseases
6.4.2. Cardiovascular Diseases
6.4.3. Orthopedic Diseases
6.4.4. Other Indications
Chapter 7. Global Cell & Gene Therapy Manufacturing Services Market , by Application
7.1. Market Snapshot
7.2. Global Cell & Gene Therapy Manufacturing Services Market by Application, Performance - Potential Analysis
7.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
7.4.1. Clinical Manufacturing
7.4.2. Commercial Manufacturing
Chapter 8. Global Cell & Gene Therapy Manufacturing Services Market , by End user
8.1. Market Snapshot
8.2. Global Cell & Gene Therapy Manufacturing Services Market by End user, Performance - Potential Analysis
8.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by End user 2018-2027 (USD Billion)
8.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
8.4.1. Pharmaceutical & Biotechnology Companies
8.4.2. Academic & Research Institutes
8.4.3. Other End Users
Chapter 9. Global Cell & Gene Therapy Manufacturing Services Market , Regional Analysis
9.1. Cell & Gene Therapy Manufacturing Services Market , Regional Market Snapshot
9.2. North America Cell & Gene Therapy Manufacturing Services Market
9.2.1. U.S. Cell & Gene Therapy Manufacturing Services Market
9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Indication breakdown estimates & forecasts, 2018-2027
9.2.1.3. Application breakdown estimates & forecasts, 2018-2027
9.2.1.4. End user breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Cell & Gene Therapy Manufacturing Services Market
9.3. Europe Cell & Gene Therapy Manufacturing Services Market Snapshot
9.3.1. U.K. Cell & Gene Therapy Manufacturing Services Market
9.3.2. Germany Cell & Gene Therapy Manufacturing Services Market
9.3.3. France Cell & Gene Therapy Manufacturing Services Market
9.3.4. Spain Cell & Gene Therapy Manufacturing Services Market
9.3.5. Italy Cell & Gene Therapy Manufacturing Services Market
9.3.6. Rest of Europe Cell & Gene Therapy Manufacturing Services Market
9.4. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market Snapshot
9.4.1. China Cell & Gene Therapy Manufacturing Services Market
9.4.2. India Cell & Gene Therapy Manufacturing Services Market
9.4.3. Japan Cell & Gene Therapy Manufacturing Services Market
9.4.4. Australia Cell & Gene Therapy Manufacturing Services Market
9.4.5. South Korea Cell & Gene Therapy Manufacturing Services Market
9.4.6. Rest of Asia Pacific Cell & Gene Therapy Manufacturing Services Market
9.5. Latin America Cell & Gene Therapy Manufacturing Services Market Snapshot
9.5.1. Brazil Cell & Gene Therapy Manufacturing Services Market
9.5.2. Mexico Cell & Gene Therapy Manufacturing Services Market
9.6. Rest of The World Cell & Gene Therapy Manufacturing Services Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck KGaA
10.2.3. Charles River Laboratories
10.2.4. Lonza
10.2.5. Catalent, Inc.
10.2.6. Takara Bio Inc.
10.2.7. FUJIFILM Holdings Corporation
10.2.8. F. Hoffmann-La Roche Ltd.
10.2.9. The Discovery Labs LLC
10.2.10. Cell and Gene Therapy Catapult
Chapter 11. Research Indication
11.1. Research Indication
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Cell & Gene Therapy Manufacturing Services Market , by Region, 2019-2027 (USD Billion)
1.2.2. Cell & Gene Therapy Manufacturing Services Market , by Type, 2019-2027 (USD Billion)
1.2.3. Cell & Gene Therapy Manufacturing Services Market , by Indication, 2019-2027 (USD Billion)
1.2.4. Cell & Gene Therapy Manufacturing Services Market , by Application, 2019-2027 (USD Billion)
1.2.5. Cell & Gene Therapy Manufacturing Services Market , by End user, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell & Gene Therapy Manufacturing Services Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell & Gene Therapy Manufacturing Services Market Dynamics
3.1. Cell & Gene Therapy Manufacturing Services Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. High incidence of cancer and other target diseases
3.1.1.2. Increasing investments in pharmaceutical R&D
3.1.2. Market Restraint
3.1.2.1. High operational costs associated with cell & gene therapy manufacturing
3.1.3. Market Opportunities
3.1.3.1. Rising demand for cell & gene therapies
Chapter 4. Global Cell & Gene Therapy Manufacturing Services Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cell & Gene Therapy Manufacturing Services Market , by Type
5.1. Market Snapshot
5.2. Global Cell & Gene Therapy Manufacturing Services Market by Type , Performance - Potential Analysis
5.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
5.4.1. Cell Therapy
5.4.2. Gene Therapy
Chapter 6. Global Cell & Gene Therapy Manufacturing Services Market , by Indication
6.1. Market Snapshot
6.2. Global Cell & Gene Therapy Manufacturing Services Market by Indication, Performance - Potential Analysis
6.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
6.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
6.4.1. Oncology Diseases
6.4.2. Cardiovascular Diseases
6.4.3. Orthopedic Diseases
6.4.4. Other Indications
Chapter 7. Global Cell & Gene Therapy Manufacturing Services Market , by Application
7.1. Market Snapshot
7.2. Global Cell & Gene Therapy Manufacturing Services Market by Application, Performance - Potential Analysis
7.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
7.4.1. Clinical Manufacturing
7.4.2. Commercial Manufacturing
Chapter 8. Global Cell & Gene Therapy Manufacturing Services Market , by End user
8.1. Market Snapshot
8.2. Global Cell & Gene Therapy Manufacturing Services Market by End user, Performance - Potential Analysis
8.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by End user 2018-2027 (USD Billion)
8.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
8.4.1. Pharmaceutical & Biotechnology Companies
8.4.2. Academic & Research Institutes
8.4.3. Other End Users
Chapter 9. Global Cell & Gene Therapy Manufacturing Services Market , Regional Analysis
9.1. Cell & Gene Therapy Manufacturing Services Market , Regional Market Snapshot
9.2. North America Cell & Gene Therapy Manufacturing Services Market
9.2.1. U.S. Cell & Gene Therapy Manufacturing Services Market
9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Indication breakdown estimates & forecasts, 2018-2027
9.2.1.3. Application breakdown estimates & forecasts, 2018-2027
9.2.1.4. End user breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Cell & Gene Therapy Manufacturing Services Market
9.3. Europe Cell & Gene Therapy Manufacturing Services Market Snapshot
9.3.1. U.K. Cell & Gene Therapy Manufacturing Services Market
9.3.2. Germany Cell & Gene Therapy Manufacturing Services Market
9.3.3. France Cell & Gene Therapy Manufacturing Services Market
9.3.4. Spain Cell & Gene Therapy Manufacturing Services Market
9.3.5. Italy Cell & Gene Therapy Manufacturing Services Market
9.3.6. Rest of Europe Cell & Gene Therapy Manufacturing Services Market
9.4. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market Snapshot
9.4.1. China Cell & Gene Therapy Manufacturing Services Market
9.4.2. India Cell & Gene Therapy Manufacturing Services Market
9.4.3. Japan Cell & Gene Therapy Manufacturing Services Market
9.4.4. Australia Cell & Gene Therapy Manufacturing Services Market
9.4.5. South Korea Cell & Gene Therapy Manufacturing Services Market
9.4.6. Rest of Asia Pacific Cell & Gene Therapy Manufacturing Services Market
9.5. Latin America Cell & Gene Therapy Manufacturing Services Market Snapshot
9.5.1. Brazil Cell & Gene Therapy Manufacturing Services Market
9.5.2. Mexico Cell & Gene Therapy Manufacturing Services Market
9.6. Rest of The World Cell & Gene Therapy Manufacturing Services Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck KGaA
10.2.3. Charles River Laboratories
10.2.4. Lonza
10.2.5. Catalent, Inc.
10.2.6. Takara Bio Inc.
10.2.7. FUJIFILM Holdings Corporation
10.2.8. F. Hoffmann-La Roche Ltd.
10.2.9. The Discovery Labs LLC
10.2.10. Cell and Gene Therapy Catapult
Chapter 11. Research Indication
11.1. Research Indication
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
no record found